Singapore markets open in 7 minutes

Teladoc Health, Inc. (TDOC)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
26.81-0.22 (-0.81%)
At close: 04:00PM EDT
26.63 -0.18 (-0.67%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 4.37B
Enterprise value 5.08B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)1.94
Price/book (mrq)0.72
Enterprise value/revenue 2.27
Enterprise value/EBITDA -0.53

Trading information

Stock price history

Beta (5Y monthly) 0.93
52-week change 3-79.33%
S&P500 52-week change 3-14.01%
52-week high 3156.82
52-week low 324.67
50-day moving average 332.80
200-day moving average 351.34

Share statistics

Avg vol (3-month) 34.96M
Avg vol (10-day) 35.06M
Shares outstanding 5161.66M
Implied shares outstanding 6N/A
Float 8159.79M
% held by insiders 11.19%
% held by institutions 186.38%
Shares short (14 Sept 2022) 432.12M
Short ratio (14 Sept 2022) 47.73
Short % of float (14 Sept 2022) 422.66%
Short % of shares outstanding (14 Sept 2022) 419.87%
Shares short (prior month 14 Aug 2022) 431.68M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022


Profit margin 0.00%
Operating margin (ttm)-9.92%

Management effectiveness

Return on assets (ttm)-1.08%
Return on equity (ttm)-89.39%

Income statement

Revenue (ttm)2.23B
Revenue per share (ttm)13.93
Quarterly revenue growth (yoy)17.70%
Gross profit (ttm)1.38B
Net income avi to common (ttm)-9.87B
Diluted EPS (ttm)-43.42
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)883.7M
Total cash per share (mrq)5.47
Total debt (mrq)1.61B
Total debt/equity (mrq)26.47
Current ratio (mrq)3.38
Book value per share (mrq)37.58

Cash flow statement

Operating cash flow (ttm)220.52M
Levered free cash flow (ttm)242.73M